Telehealth in breast cancer following the coronavirus disease 2019 pandemic
Breast cancer (BC) is the second most diagnosed cancer in 2018 with around 2.3 million cases globally in 2020. In March 2020 and after its worldwide spread, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak, a respiratory disease caused by the severe acute...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2023-12-01
|
| Series: | Exploration of Targeted Anti-tumor Therapy |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/Journals/etat/Article/1002195 |
| _version_ | 1797374218697965568 |
|---|---|
| author | Jean Zeghondy Elie Rassy Pietro Lapidari Roland Eid Barbara Pistilli |
| author_facet | Jean Zeghondy Elie Rassy Pietro Lapidari Roland Eid Barbara Pistilli |
| author_sort | Jean Zeghondy |
| collection | DOAJ |
| description | Breast cancer (BC) is the second most diagnosed cancer in 2018 with around 2.3 million cases globally in 2020. In March 2020 and after its worldwide spread, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak, a respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, a pandemic. During this time, cancer patients were heavily impacted and their treatment plans were changed due to measures to fight the disease and solutions had to be found to maintain their follow-up and management from a distance. Some cancer groups worldwide have recommended then the use of telemedicine for oncology patients to ensure the continuity of medical care during the pandemic. This method was considered effective and clinicians worldwide continued using telehealth even after the cessation of worldwide restrictions. To this end, current up-to-date data on the use of telemedicine in BC patient after the COVID-19 outbreak are summarized in this narrative review. |
| first_indexed | 2024-03-08T19:01:45Z |
| format | Article |
| id | doaj.art-57cf4ec8df5646d3b022e6a56e47044f |
| institution | Directory Open Access Journal |
| issn | 2692-3114 |
| language | English |
| last_indexed | 2024-03-08T19:01:45Z |
| publishDate | 2023-12-01 |
| publisher | Open Exploration Publishing Inc. |
| record_format | Article |
| series | Exploration of Targeted Anti-tumor Therapy |
| spelling | doaj.art-57cf4ec8df5646d3b022e6a56e47044f2023-12-28T05:15:22ZengOpen Exploration Publishing Inc.Exploration of Targeted Anti-tumor Therapy2692-31142023-12-01461249125910.37349/etat.2023.00195Telehealth in breast cancer following the coronavirus disease 2019 pandemicJean Zeghondy0https://orcid.org/0000-0001-8811-4085Elie Rassy1https://orcid.org/0000-0002-7906-0991Pietro Lapidari2Roland Eid3Barbara Pistilli4https://orcid.org/0000-0002-9184-7199Medical Oncology Department, Gustave Roussy, F-94805 Villejuif, FranceMedical Oncology Department, Gustave Roussy, F-94805 Villejuif, FranceMedical Oncology Department, Gustave Roussy, F-94805 Villejuif, FranceMedical Oncology Department, Gustave Roussy, F-94805 Villejuif, FranceMedical Oncology Department, Gustave Roussy, F-94805 Villejuif, FranceBreast cancer (BC) is the second most diagnosed cancer in 2018 with around 2.3 million cases globally in 2020. In March 2020 and after its worldwide spread, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak, a respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, a pandemic. During this time, cancer patients were heavily impacted and their treatment plans were changed due to measures to fight the disease and solutions had to be found to maintain their follow-up and management from a distance. Some cancer groups worldwide have recommended then the use of telemedicine for oncology patients to ensure the continuity of medical care during the pandemic. This method was considered effective and clinicians worldwide continued using telehealth even after the cessation of worldwide restrictions. To this end, current up-to-date data on the use of telemedicine in BC patient after the COVID-19 outbreak are summarized in this narrative review.https://www.explorationpub.com/Journals/etat/Article/1002195telehealthtelemedicinebreast cancerbreast neoplasmscoronavirus disease 2019pandemic |
| spellingShingle | Jean Zeghondy Elie Rassy Pietro Lapidari Roland Eid Barbara Pistilli Telehealth in breast cancer following the coronavirus disease 2019 pandemic Exploration of Targeted Anti-tumor Therapy telehealth telemedicine breast cancer breast neoplasms coronavirus disease 2019 pandemic |
| title | Telehealth in breast cancer following the coronavirus disease 2019 pandemic |
| title_full | Telehealth in breast cancer following the coronavirus disease 2019 pandemic |
| title_fullStr | Telehealth in breast cancer following the coronavirus disease 2019 pandemic |
| title_full_unstemmed | Telehealth in breast cancer following the coronavirus disease 2019 pandemic |
| title_short | Telehealth in breast cancer following the coronavirus disease 2019 pandemic |
| title_sort | telehealth in breast cancer following the coronavirus disease 2019 pandemic |
| topic | telehealth telemedicine breast cancer breast neoplasms coronavirus disease 2019 pandemic |
| url | https://www.explorationpub.com/Journals/etat/Article/1002195 |
| work_keys_str_mv | AT jeanzeghondy telehealthinbreastcancerfollowingthecoronavirusdisease2019pandemic AT elierassy telehealthinbreastcancerfollowingthecoronavirusdisease2019pandemic AT pietrolapidari telehealthinbreastcancerfollowingthecoronavirusdisease2019pandemic AT rolandeid telehealthinbreastcancerfollowingthecoronavirusdisease2019pandemic AT barbarapistilli telehealthinbreastcancerfollowingthecoronavirusdisease2019pandemic |